PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.77%
Revenue growth above 1.5x 1177.HK's 0.79%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.75%
Gross profit growth above 1.5x 1177.HK's 5.20%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-32.01%
Negative EBIT growth while 1177.HK is at 4.19%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-105.70%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-32.00%
Negative net income growth while 1177.HK stands at 45.64%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.08%
Negative EPS growth while 1177.HK is at 48.10%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-36.92%
Negative diluted EPS growth while 1177.HK is at 49.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
3.07%
Slight or no buybacks while 1177.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
8.83%
Slight or no buyback while 1177.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-11.66%
Negative OCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.97%
Negative FCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
594344.75%
10Y CAGR of 594344.75% while 1177.HK is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
2498.60%
5Y revenue/share CAGR above 1.5x 1177.HK's 77.74%. David Dodd would look for consistent product or market expansions fueling outperformance.
381.85%
3Y revenue/share CAGR above 1.5x 1177.HK's 26.85%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-11.76%
Negative 10Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
278.35%
Positive OCF/share growth while 1177.HK is negative. John Neff might see a comparative advantage in operational cash viability.
302.35%
Positive 3Y OCF/share CAGR while 1177.HK is negative. John Neff might see a big short-term edge in operational efficiency.
522.96%
10Y net income/share CAGR of 522.96% while 1177.HK is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
111.42%
Below 50% of 1177.HK's 255.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
160.68%
3Y net income/share CAGR 75-90% of 1177.HK's 191.74%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
158.32%
Equity/share CAGR of 158.32% while 1177.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-16.81%
Negative 5Y equity/share growth while 1177.HK is at 131.42%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-0.02%
Negative 3Y equity/share growth while 1177.HK is at 40.90%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1177.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.86%
Inventory growth well above 1177.HK's 6.91%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.28%
Positive asset growth while 1177.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.20%
Positive BV/share change while 1177.HK is negative. John Neff sees a clear edge over a competitor losing equity.
16.40%
We have some new debt while 1177.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
35.93%
SG&A growth well above 1177.HK's 1.17%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.